Table 4 ARID1A mutation in different cancers.

From: Comprehensive genomic profiling reveals a unique genomic landscape in solid tumors in an Indian cancer cohort of 1000 patients: a single institutional experience

Cancer

Cancer Subtype

MSI

TMB

FGT (n = 16)

Ca Endometrial (n = 5)

0–52.9 (Mean 18.49)

4.9–26.9 (Mean 14.34)

Carcinoma Ovary (4)

0.85–42 (Mean 13.03)

2.5–44.4 (14.35)

Cervix (1)

3.2

15.1

Other (1)

HPB(n = 7)

Ca Pancreas (4)

3.23–4.1 (Mean 3.52)

6.7–12.2 (Mean 6.7–12.2)

Cholangiocarcinoma (2)

0.81–4 (Mean 2.4)

2.5–6.4 (Mean 4.45)

HCC (1)

4.84

11.7

GIT (N = 7)

Ca Colon (6)

0–11.7 (Mean 8.35)

0–665.6 (Mean 228.3)

Ca Stomach(1)

6.45

4.2

H&N (4)

Adenoid Cystic Ca (2)

3.42–4 (Mean 3.71)

6.5–8.2 (Mean 7.35)

Carcinoma Supraglottis SCC(1)

2.42

4.3

Medullary thyroid(1)

0.83

1.7

Breast (n = 4)

ER + PR + HER2-(1)

6.9

3.5

ER + PR + Her2-(2)

TNBC (1)

1.64

12.8

Lung (n = 5)

NSCLC (2)

0.81

99.3

CUP (n = 2)

CUP (1)

4.84

13.3